Multicenter study of wound healing in neurofibromatosis and neurofibroma
- PMID: 17912073
- DOI: 10.1097/scs.0b013e31811f3587
Multicenter study of wound healing in neurofibromatosis and neurofibroma
Abstract
Based on clinical experience, the senior author has become convinced that wounds produced to correct the deformities of patients with neurofibromatosis (NF-1) have produced remarkably good scars, the interesting feature being that progression to keloid or hypertrophic scar is rare. The other point noted was that this situation did not change, no matter the patient's race or skin color. There have been few reports describing or discussing this hypothesis. The purpose of this study was to investigate whether wounds produced in the patients with NF-1 produce keloid or hypertrophic scars. The patients with solitary neurofibroma were also included in this study; these were compared with the NF-1 group. This was conducted as a multicenter study. Patients with neurofibromatosis/solitary neurofibroma, who were operated on from 1990 to 2000, were evaluated by reviewing their medical charts and photographs retrospectively. The patients were treated in centers from five different countries. The analysis was undertaken based on the following points: 1) age and sex at surgery; 2) race of the patients; 3) past and family histories of hypertrophic scar and keloid; 4) surgical site(s); 5) diagnosis, NF1 or solitary neurofibroma; 6) surgical complications; 7) number of reoperations to manage the complications; 8) adjuvant therapy for the tumor; 9) depth of the tumors; and 10) incidence of malignant degeneration. A total of 101 cases with neurofibromatosis or solitary neurofibroma was analyzed. The age at surgery ranged from 1 year 6 months to 74 years; sex ratio was 47 males and 54 females. The racial distribution of the patients was 13 white, 13 black, 3 Hispanic, and 58 Asian. There was no past or family history of hypertrophic scar or keloid. The surgical sites were head and neck in 70 cases, trunk in 20 cases, upper extremities in 22 cases, and lower extremities in 20 cases. The clinical diagnosis was NF-1 in 57 cases, solitary neurofibroma in 35 cases, plexiform neurofibroma in four cases, and no distinct clinical diagnosis in five cases. There were no other types of neurofibromatosis. Hematoma and white wide scar were the main postoperative complications found in six cases of NF-1. Infection was also noted in four cases. However, no patient developed hypertrophic scar or keloid in the neurofibromatosis group, whereas two cases showed hypertrophic scar in the solitary neurofibroma group. The outcome showed that the patients with NF-1 and plexiform neurofibroma, no matter the racial group, produce good scars without keloid or hypertrophic changes, whereas solitary neurofibroma has a potential to cause hypertrophic scar.
Similar articles
-
Keloid disease: clinical relevance of single versus multiple site scars.Br J Plast Surg. 2005 Jan;58(1):28-37. doi: 10.1016/j.bjps.2004.04.024. Br J Plast Surg. 2005. PMID: 15629164
-
Incidence of hypertrophic and keloid scars after N-butyl 2-cyanoacrylate tissue adhesive had been used to close parotidectomy wounds: a prospective study of 100 consecutive patients.Br J Oral Maxillofac Surg. 2009 Jun;47(4):290-3. doi: 10.1016/j.bjoms.2009.01.011. Epub 2009 Feb 26. Br J Oral Maxillofac Surg. 2009. PMID: 19249145
-
The use of silicone gel in the treatment of fresh surgical scars: a randomized study.Clin Exp Dermatol. 2009 Aug;34(6):688-93. doi: 10.1111/j.1365-2230.2008.03096.x. Epub 2009 Mar 14. Clin Exp Dermatol. 2009. PMID: 19508580 Clinical Trial.
-
Low-dose enalapril in the treatment of surgical cutaneous hypertrophic scar and keloid--two case reports and literature review.MedGenMed. 2006 Dec 20;8(4):60. MedGenMed. 2006. PMID: 17415337 Free PMC article. Review.
-
Neurofibroma of the urinary bladder.Cancer. 1999 Aug 1;86(3):505-13. Cancer. 1999. PMID: 10430260 Review.
Cited by
-
Neurofibromatosis type 1-associated plexiform neurofibromas of the neck: topography of lesions and surgical treatment data of 69 patients.Oral Maxillofac Surg. 2024 Mar;28(1):393-404. doi: 10.1007/s10006-023-01155-5. Epub 2023 May 13. Oral Maxillofac Surg. 2024. PMID: 37173460 Free PMC article.
-
Peripheral nerve sheath tumors of the upper extremity and hand in patients with neurofibromatosis type 1: topography of tumors and evaluation of surgical treatment in 62 patients.GMS Interdiscip Plast Reconstr Surg DGPW. 2017 Dec 5;6:Doc15. doi: 10.3205/iprs000117. eCollection 2017. GMS Interdiscip Plast Reconstr Surg DGPW. 2017. PMID: 29214122 Free PMC article.
-
Dermatologic Manifestations of Neurofibromatosis Type 1 and Emerging Treatments.Cancers (Basel). 2023 May 16;15(10):2770. doi: 10.3390/cancers15102770. Cancers (Basel). 2023. PMID: 37345107 Free PMC article. Review.
-
Mechanobiological dysregulation of the epidermis and dermis in skin disorders and in degeneration.J Cell Mol Med. 2013 Jul;17(7):817-22. doi: 10.1111/jcmm.12060. Epub 2013 May 15. J Cell Mol Med. 2013. PMID: 23672502 Free PMC article. Review.
-
Frequency of Acne and Acne Scars in Patients with Neurofibromatosis 1.Acta Derm Venereol. 2024 Jan 10;104:adv18621. doi: 10.2340/actadv.v104.18621. Acta Derm Venereol. 2024. PMID: 38197700 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous